Eckardt J - Search Results

1

Heat shock proteins and drug resistance.

Fuqua SA, Oesterreich S, Hilsenbeck SG, Von Hoff DD, Eckardt J, Osborne CK. Fuqua SA, et al. Among authors: eckardt j. Breast Cancer Res Treat. 1994;32(1):67-71. doi: 10.1007/BF00666207. Breast Cancer Res Treat. 1994. PMID: 7819588 Review.

2

New drugs in clinical development in the United States.

Eckardt JR, Von Hoff DD. Eckardt JR, et al. Hematol Oncol Clin North Am. 1994 Apr;8(2):305-32. Hematol Oncol Clin North Am. 1994. PMID: 8040143 Review.

3

Activity of intoplicine (RP60475), a new DNA topoisomerase I and II inhibitor, against human tumor colony-forming units in vitro.

Eckardt JR, Burris HA 3rd, Kuhn JG, Bissery MC, Klink-Alakl M, Clark GM, Von Hoff DD. Eckardt JR, et al. J Natl Cancer Inst. 1994 Jan 5;86(1):30-3. doi: 10.1093/jnci/86.1.30. J Natl Cancer Inst. 1994. PMID: 8271279

4

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

Rothenberg ML, Eckardt JR, Kuhn JG, Burris HA 3rd, Nelson J, Hilsenbeck SG, Rodriguez GI, Thurman AM, Smith LS, Eckhardt SG, Weiss GR, Elfring GL, Rinaldi DA, Schaaf LJ, Von Hoff DD. Rothenberg ML, et al. Among authors: eckardt jr. J Clin Oncol. 1996 Apr;14(4):1128-35. doi: 10.1200/JCO.1996.14.4.1128. J Clin Oncol. 1996. PMID: 8648367 Clinical Trial.

5

A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide.

Hammond LA, Eckardt JR, Ganapathi R, Burris HA, Rodriguez GA, Eckhardt SG, Rothenberg ML, Weiss GR, Kuhn JG, Hodges S, Von Hoff DD, Rowinsky EK. Hammond LA, et al. Among authors: eckardt jr. Clin Cancer Res. 1998 Jun;4(6):1459-67. Clin Cancer Res. 1998. PMID: 9626463 Clinical Trial.

6

A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusion.

Rodriguez GI, Kuhn JG, Weiss G, De La Cruz P, New P, Fields SM, Eckardt JR, Campbell L, Clark GM, Hilsenbeck SG, Von Hoff DD. Rodriguez GI, et al. Among authors: eckardt jr. Invest New Drugs. 1998;16(1):57-67. doi: 10.1023/a:1006003718255. Invest New Drugs. 1998. PMID: 9740545 Clinical Trial.

7

A randomized phase I and pharmacological trial of sequences of 1,3-bis(2-chloroethyl)-1-nitrosourea and temozolomide in patients with advanced solid neoplasms.

Hammond LA, Eckardt JR, Kuhn JG, Gerson SL, Johnson T, Smith L, Drengler RL, Campbell E, Weiss GR, Von Hoff DD, Rowinsky EK. Hammond LA, et al. Clin Cancer Res. 2004 Mar 1;10(5):1645-56. doi: 10.1158/1078-0432.ccr-03-0174. Clin Cancer Res. 2004. PMID: 15014015 Clinical Trial.

8

Preclinical and phase I trials of topoisomerase I inhibitors.

Von Hoff DD, Burris HA 3rd, Eckardt J, Rothenberg M, Fields SM, Chen SF, Kuhn JG. Von Hoff DD, et al. Among authors: eckardt j. Cancer Chemother Pharmacol. 1994;34 Suppl:S41-5. doi: 10.1007/BF00684862. Cancer Chemother Pharmacol. 1994. PMID: 8070026 Clinical Trial.

9

Phase I and pharmacokinetic trial of weekly CPT-11.

Rothenberg ML, Kuhn JG, Burris HA 3rd, Nelson J, Eckardt JR, Tristan-Morales M, Hilsenbeck SG, Weiss GR, Smith LS, Rodriguez GI, et al. Rothenberg ML, et al. Among authors: eckardt jr. J Clin Oncol. 1993 Nov;11(11):2194-204. doi: 10.1200/JCO.1993.11.11.2194. J Clin Oncol. 1993. PMID: 8229134 Clinical Trial.

10

A randomized phase I study of oral etoposide with or without granulocyte-macrophage colony-stimulating factor for the treatment of patients with advanced cancer.

Weiss GR, Shaffer DW, DeMoor C, Rinaldi DA, Rodriguez GI, Eckardt JR, Stephens C, Von Hoff DD. Weiss GR, et al. Among authors: eckardt jr. Anticancer Drugs. 1996 Jun;7(4):402-9. doi: 10.1097/00001813-199606000-00005. Anticancer Drugs. 1996. PMID: 8826608 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

333 results

Search Page